Background: The outbreak of COVID-19 has a significant impact on the health of people around the world. In the clinical condition of COVID-19, the condition of critical cases changes rapidly with a high mortality rate. Therefore, early prediction of disease severity and active intervention play an important role in the prognosis of severe patients. Methods: All the patients with COVID-19 in Taizhou city were retrospectively included and segregated into the non-severe and severe group according to the severity of the disease. The clinical manifestations, laboratory examination results, and imaging findings of the 2 groups were analyzed for comparing the differences between the 2 groups. Univariate and multivariate logistic regression were used for screening the factors that could predict the disease, and the nomogram was constructed. Results: A total of 143 laboratory-confirmed cases were included in the study, including 110 non-severe patients and 33 severe patients. The median age of patients was 47 years (range, 4 - 86 years). Fever (73.4%) and cough (63.6%) were the most common initial clinical symptoms. By using the method of multivariate logistic regression, the variables to construct nomogram include age (OR: 1.052, 95% CI: 1.020 - 1.086, P = 0.001), body temperature (OR: 2.252, 95% CI: 1.139 - 4.450, P = 0.020), lymphocyte count (OR: 1.128, 95% CI: 1.000 - 1.272, P = 0.049), ADA (OR: 1.163, 95% CI: 1.023 - 1.323, P = 0.021), PaO 2 (OR: 0.972, 95% CI: 0.953 - 0.992, P = 0.007), IL-10 (OR: 1.184, 95% CI: 1.037 - 1.351, P = 0.012), and bronchiectasis (OR: 3.818, 95% CI: 1.694 - 8.605, P = 0.001). The AUC of the established nomogram was 0.877. Conclusions: This study analyzed the cases of patients with COVID-19 in Taizhou city and constructed a model to predict the illness severity. When patients showed the features including older age, high body temperature, low lymphocyte count, low ADA value, low PaO 2 , high IL-10, and bronchiectasis sign in CT predicts a greater likelihood of severe COVID-19.
Wang, W., Tang, J. and Wei, F. (2020) Updated Understanding of the Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, 92, 441-447. http://www.ncbi.nlm.nih.gov/pubmed/31994742 https://doi.org/10.1002/jmv.25689
Hui, D.S., Azhar, I.E., Madani, T.A., Ntoumi, F., Kock, R., Dar, O., et al. (2020) The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health: The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264-266. https://doi.org/10.1016/j.ijid.2020.01.009
Bassetti, M., Vena, A. and Roberto, G.D. (2020) The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for Fighting the Storm. European Journal of Clinical Investigation, 50, e13209. https://doi.org/10.1111/eci.13209
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet, 395, 565-574. https://doi.org/10.1016/S0140-6736(20)30251-8
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. (2020) Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine, 382, 970-971. https://doi.org/10.1056/NEJMc2001468
Phan, L.T., Nguyen, T.V., Luong, Q.C., Nguyen, T.V., Nguyen, H.T., Le, H.Q., et al. (2020) Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. New England Journal of Medicine, 382, 872-874. https://doi.org/10.1056/NEJMc2001272
Chan, J.F.W., Yuan, S., Kok, K.H., To, K.K.W., Chu, H., Yang, J., et al. (2020) A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster. The Lancet, 395, 514-523. https://doi.org/10.1016/S0140-6736(20)30154-9
Wu, J.T., Leung, K. and Leung, G.M. (2020) Nowcasting and Forecasting the Potential Domestic and International Spread of the 2019-nCoV Outbreak Originating in Wuhan, China: A Modelling Study. The Lancet, 395, 689-697. https://doi.org/10.1016/S0140-6736(20)30260-9
China D. Dingxiang Garden, Doctor Dingxiang, Real-Time Status of New Coronavirus Pneumonia. 5. https://ncov.dxy.cn/ncovh5/view/pneumonia?from=singlemessage&isappinstalled=0
Ren, W., Qu, X., Li, W., Han, Z., Yu, M., Zhou, P., et al. (2008) Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin. Journal of Virology, 82, 1899-1907. http://jvi.asm.org/content/82/4/1899.abstract https://doi.org/10.1128/JVI.01085-07
Maier, H.J., Bickerton, E. and Britton, P. (2015) Coronaviruses: An Overview of Their Replication and Pathogenesis. Coronaviruses—Methods and Protocols, 1282, 1-23. https://doi.org/10.1007/978-1-4939-2438-7
Hemida, M.G., Elmoslemany, A., Al-hizab, F., Alnaeem, A., Almathen, F., Faye, B., et al. (2018) Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Transboundary and Emerging Diseases, 64, 344-353. https://doi.org/10.1111/tbed.12401
Kucharski, A.J. and Althaus, C.L. (2015) The Role of Superspreading in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Transmission. Eurosurveillance, 20, 14-18. https://doi.org/10.2807/1560-7917.ES2015.20.25.21167
Mackay, I.M. and Arden, K.E. (2015) MERS Coronavirus: Diagnostics, Epidemiology and Transmission. Virology Journal, 12, Article No. 222. https://doi.org/10.1186/s12985-015-0439-5
Azhar, E.I., Hui, D.S.C., Memish, Z.A., Drosten, C. and Zumla, A. (2019) The Middle East Respiratory Syndrome (MERS). Infectious Disease Clinics of North America, 33, 891-905. https://doi.org/10.1016/j.idc.2019.08.001
Lim, J., Jeon, S., Shin, H.Y., Kim, M.J., Seong, Y.M., Lee, W.J., et al. (2020) Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: The Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. Journal of Korean Medical Science, 35, e79. https://pubmed.ncbi.nlm.nih.gov/32056407 https://doi.org/10.3346/jkms.2020.35.e89
COVID-19 National Incident Room Surveillance Team (2020) COVID-19, Australia: Epidemiology Report 2 (Reporting Week Ending 19:00 AEDT 8 February 2020). Communicable Diseases Intelligence, 12, 44. https://pubmed.ncbi.nlm.nih.gov/32050080 https://doi.org/10.33321/cdi.2020.44.14
Status, C., Ahn, D., Shin, H., Kim, M., Lee, S., Kim, H., et al. (2020) Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). Journal of Microbiolog and Biotechnology, 30, 313-324. https://doi.org/10.4014/jmb.2003.03011
New Coronavirus Diagnosis and Treatment Protocol (Trial Version 5). Chinese Journal of Integrated Traditional and Western Medicine, 1-3. http://kns.cnki.net/kcms/detail/11.2787.R.20200208.1034.002.htm
Zhang, S.Y., Lian, J.S., Hu, J.H., Zhang, X.L., Lu, Y.F., Cai, H., et al. (2020) Clinical Characteristics of Different Subtypes and Risk Factors for the Severity of Illness in Patients with COVID-19 in Zhejiang, China. Infectious Diseases of Poverty, 9, Article No. 85. https://doi.org/10.1186/s40249-020-00710-6
Lian, J., Jin, X., Hao, S., Jia, H., Cai, H., Zhang, X., et al. (2020) Epidemiological, Clinical, and Virological Characteristics of 465 Hospitalized Cases of Coronavirus Disease 2019 (COVID-19) from Zhejiang Province in China. Influenza and Other Respiratory Viruses, 14, 564-574. https://doi.org/10.1111/irv.12758
Wang, S., Chen, Z., Lin, Y., Lin, L., Lin, Q., Fang, S., et al. (2020) Clinical Characteristics of 199 Discharged Patients with COVID-19 in Fujian Province: A Multicenter Retrospective Study between January 22nd and February 27th, 2020. PLoS ONE, 15, e0242307. https://doi.org/10.1371/journal.pone.0242307
Jin, X., Lian, J.S., Hu, J.H., Gao, J., Zheng, L., Zhang, Y.M., et al. (2020) Epidemiological, Clinical and Virological Characteristics of 74 Cases of Coronavirus-Infected Disease 2019 (COVID-19) with Gastrointestinal Symptoms. Gut, 69, 1002-1009. https://doi.org/10.1136/gutjnl-2020-320926
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020) Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. New England Journal of Medicine, 1-9.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
Liu, W.J., Zhao, M., Liu, K., Xu, K., Wong, G., Tan, W., et al. (2017) T-Cell Immunity of SARS-CoV: Implications for Vaccine Development against MERS-CoV. Antiviral Research, 137, 82-92. https://doi.org/10.1016/j.antiviral.2016.11.006
Saghazadeh, A. and Rezaei, N. (2020) Immune-Epidemiological Parameters of the Novel Coronavirus—A Perspective. Expert Review of Clinical Immunology, 16, 465-470. https://doi.org/10.1080/1744666X.2020.1750954
Pinsky, M.R. (2004) Dysregulation of the Immune Response in Severe Sepsis. The American Journal of the Medical Sciences, 328, 220-229. https://doi.org/10.1097/00000441-200410000-00005
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., et al. (2020) Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3541136
Agosto, L.M. and Henderson, A.J. (2018) CD4+ T Cell Subsets and Pathways to HIV Latency. AIDS Research and Human Retroviruses, 34, 780-789. https://doi.org/10.1089/aid.2018.0105
Akiyama, H., Miller, C.M., Ettinger, C.R., Belkina, A.C., Snyder-Cappione, J.E. and Gummuluru, S. (2018) HIV-1 Intron-Containing RNA Expression Induces Innate Immune Activation and T Cell Dysfunction. Nature Communications, 9, 3450. https://doi.org/10.1038/s41467-018-05899-7
Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., et al. (2020) Clinical Characteristics and Imaging Manifestations of the 2019 Novel Coronavirus Disease (COVID-19): A Multi-Center Study in Wenzhou City, Zhejiang, China. Journal of Infection, 80, 388-393. https://doi.org/10.1016/j.jinf.2020.02.016
Wang, F., Qu, M., Zhou, X., Zhao, K., Lai, C., Tang, Q., et al. (2020) The Timeline and Risk Factors of Clinical Progression of COVID-19 in Shenzhen, China. Journal of Translational Medicine, 18, Article No. 270. https://doi.org/10.1186/s12967-020-02423-8